Literature DB >> 2911608

Lysozyme-induced inhibition of the lymphocyte response to mitogenic lectins.

P E Varaldo1, S Valisena, M C Mingari, G Satta.   

Abstract

Both human lysozyme (HL) and hen egg white lysozyme (HEWL) inhibited the proliferative response of peripheral blood lymphocytes to T cell mitogens such as the lectins phytohemagglutinin and concanavalin A. This inhibition was observed both when HL or HEWL was added to the lymphocyte cultures in combination with phytohemagglutinin or concanavalin A and when lymphocytes were pretreated with either lysozyme and extensively washed prior to culture with mitogens. Under both conditions, the effects were strictly dose dependent; the lysozyme concentrations yielding maximal inhibitory effect were 5 micrograms/ml for HL and 1 microgram/ml for HEWL, while both lower and higher concentrations were less effective. Specific antilysozyme rabbit sera completely prevented the inhibitory effects of both HL and HEWL on the proliferative response of lymphocytes to phytohemagglutin or concanavalin A. Chitotriose (a lysozyme inhibitor) caused a strong reduction in the inhibitory effects of the two lysozymes on the lymphocyte response to either lectin. HL and HEWL also were found to markedly inhibit the polyclonal B cell proliferation and differentiation induced by pokeweed mitogen and T cells. A less marked inhibition was also obtained when T cells, but not B cells, were pretreated with HL or HEWL. Again, as in the experiments with T cell mitogens, the effects were dose dependent and 5 micrograms/ml HL and 1 microgram/ml HEWL proved to be the most effective concentrations. The possible mechanisms by which lysozyme inhibits the lymphocyte response to mitogenic lectins are considered and discussed. The enzymatic activity seemed to perform an essential function, as shown by the loss of effect when the heat- or trypsin-inactivated lysozymes were used and by the fact that only the enzymatically active compound, among certain semisynthetic derivatives of HEWL, inhibited the lymphocyte response to the mitogens. However, the cationic properties of the lysozyme molecule appeared to be essential too, since enzymes with a similar specificity of action showed effects similar to those observed with HL or HEWL only when they carried a strong positive charge. It is suggested that lysozyme, which is naturally secreted by monocytes and macrophages, might interact with lymphocyte surface receptor sites and participate in the complex mononuclear phagocyte-lymphocyte interactions and in the modulation of lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911608     DOI: 10.3181/00379727-190-42829

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  6 in total

1.  Modulatory effect of rat small intestinal epithelial cell-conditioned medium on lymphocyte proliferation.

Authors:  K Tanaka; N Yabe; H Matsui
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-01       Impact factor: 2.416

2.  Staphylococcal endo-beta-N-acetylglucosaminidase inhibits response of human lymphocytes to mitogens and interferes with production of antibodies in mice.

Authors:  S Valisena; P E Varaldo; G Satta
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Activation of peripheral blood mononuclear cells in bronchoalveolar lavage fluid from patients with sarcoidosis: visualisation of single cell activation products.

Authors:  P Pantelidis; A M Southcott; A D Cambrey; G J Laurent; R M du Bois
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

4.  Lysozyme as a regulator of interleukin-2-activated lymphocyte proliferation.

Authors:  N Yabe; K Komiya; T Takezono; H Matsui
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-10       Impact factor: 2.416

5.  Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.

Authors:  Md Imran Khan; Deepu Dowarha; Revansiddha Katte; Ruey-Hwang Chou; Anna Filipek; Chin Yu
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

Review 6.  Recent Insights Into the Prognostic and Therapeutic Applications of Lysozymes.

Authors:  Lin Jiang; Yunhe Li; Liye Wang; Jian Guo; Wei Liu; Guixian Meng; Lei Zhang; Miao Li; Lina Cong; Meiyan Sun
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.